Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-DCFPyL PET Imaging in Solid Malignancies and Schwannoma
NCT03542773Phase 1Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Feb 2015
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of piflufolastat f 18 in solid tumor and schwannoma, sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoint: Determine feasibility of using 18F-DCFPyL to detect cancer at 24 months. Started Feb 2015; status: completed.
02
Drugs
piflufolastat f 18
03
Conditions
solid tumorschwannoma
Beyond the preview
Go deeper on NCT03542773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03542773.